+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Management: Blood Glucose Monitoring Devices Market (2021)

  • ID: 5357351
  • Report
  • March 2021
  • Region: Global
  • 175 pages
  • MedDeviceTracker

FEATURED COMPANIES

  • Abbott
  • Ascensia Diabetes Care
  • Dexcom
  • LifeScan
  • Medtronic
  • Roche
  • MORE
Overview

The blood glucose monitoring devices market includes: conventional handheld blood glucose meters (BGMs) that require frequent fingersticks, and new, sensor-based continuous glucose monitoring systems (CGMs) typically worn the upper arm or abdomen that conveniently monitor blood glucose 24/7, as well as lucrative supplies and software/accessories.

The burgeoning global blood glucose monitoring market is expected to increase at a healthy CAGR of 13.8%, from nearly $9.1bn in 2019, $9.8bn in 2020, to an estimated $19.7bn in 2025.

The blood glucose monitoring devices market is thriving despite the COVID-19 pandemic due in part to remote patient use and steadily increasing demand, particularly for novel CGMs such as Abbott’s FreeStyle Libre and Dexcom’s G6 CGM, which are among the fastest-growing medical device markets in the world.

Revenues for these sensor-based CGMs are quickly cannibalizing cumbersome fingerstick-based handheld BGMs due to overall convenience and the ability to continuously monitor blood glucose 24/7, eliminate painful fingersticks, sync and instantly transfer glucose data to smartphones via digital diabetes management apps that provide useful charts/trending data, instant alerts of impending high and low blood glucose, and sharing of data with caregivers/healthcare professionals. Overall, these “smart” CGMs are helping people with both type 1 and type 2 diabetes better understand their condition, achieve tighter glycemic control, and improve diabetes complications while substantially lowering healthcare costs.

The CGMs segment is expected to continue to flourish due to ongoing innovations (such as smaller, lighter, more comfortable, more accurate/improved algorithms and longer-wear sensors) and expansion into new indications such as the larger population pool of non-insulin intensive type 2 diabetes, hospital, and international markets. Meanwhile, sales of BGMs are expected to continue to decline due to cannibalization of CGMs, pricing pressures, and other factors; yet, these handheld devices will remain relevant and widely used by consumers and healthcare professionals who prefer this well-established, readily available technology. BGMs will also remain popular in areas of the world without access or affordability to more sophisticated and costly CGMs, and to supplement CGMs for infrequent calibration or to confirm glucose data.

Key competitors in the blood glucose monitoring devices market include: Abbott, Dexcom, Roche, Ascensia Diabetes Care, LifeScan, Medtronic, Senseonics, and dozens of other smaller companies.

This comprehensive medical market and technology report provides:
  • overview of type 1 and type 2 diabetes and prevalence
  • BGMs and CGM technologies, including digital diabetes management apps
  • competitive advantages/features
  • emerging technologies and innovations
  • regulatory approvals
  • in-depth market and competitive analyses (market drivers/limiters, 6-year market forecasts by segment and region, 2019 and 2020 global/regional market share)
  • overview of companies, financials, and strategic growth plans
Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. Market forecasts are for the 2019-25 time period.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Ascensia Diabetes Care
  • Dexcom
  • LifeScan
  • Medtronic
  • Roche
  • MORE
Executive Summary
  • Diabetes overview
  • Global diabetes prevalence
  • Blood glucose monitoring technology
  • Blood glucose monitoring devices market
  • Market leaders
  • Methodology
  • Bibliography
  • Exhibit ES-1: Blood glucose monitoring device sales by product segment (blood glucose meters and continuous glucose monitoring devices), combined market forecast ($m), 2019-25
  • Exhibit ES-2: Blood glucose monitoring devices market (blood glucose meters and continuous glucose monitoring devices), combined market forecast by region ($m), 2019-25
  • Exhibit ES-3: Combined blood glucose monitoring devices market (blood glucose meters and continuous glucose monitoring devices), global share by supplier ($m), 2019
  • Exhibit ES-4: Combined blood glucose monitoring devices market (blood glucose meters and continuous glucose monitoring devices), global share by supplier ($m), 2020
1. Diabetes Overview
1.1 Prevalence
1.2 Diabetes
1.2.1 Symptoms
1.2.2 Complications
1.2.3 Diagnosis and treatment
1.2.4 Cost of diabetes
1.3 Bibliography

2. Blood Glucose Monitoring Devices
2.1 Blood glucose meters
2.1.1 Abbott
2.1.2 Ascensia Diabetes Care
2.1.3 LifeScan
2.1.4 Roche
2.1.5 Livongo
2.1.6 One Drop/Apple Watch
2.2 Continuous blood glucose monitoring systems
2.2.1 Abbott
2.2.2 Dexcom
2.2.3 Medtronic
2.3 New or emerging wearable blood glucose monitoring patches
2.3.1 Nemaura Medical
2.3.2 Senseonics
2.4 Bibliography
  • Exhibit 2-1: Accuracy of blood glucose meters - top eight with lowest MARD
  • Exhibit 2-2: Selected blood glucose meter brands by manufacturer, 2021
  • Exhibit 2-3: Selected blood glucose meters and features, 2021
  • Exhibit 2-4: The FreeStyle Lite
  • Exhibit 2-5: The Contour NEXT One and Contour Diabetes app
  • Exhibit 2-6: The Contour NEXT Link 2.4
  • Exhibit 2-7: OneTouch Verio Flex meter with OneTouch Reveal app and OneTouch Verio meter
  • Exhibit 2-8: OneTouch Reveal Plus powered by Welldoc’s BlueStar intelligent diabetes coaching technology
  • Exhibit 2-9: Welldoc’s BlueStar diabetes AI-driven smart app
  • Exhibit 2-10: New OneTouch Verio Reflect with Blood Sugar Mentor
  • Exhibit 2-11: The Accu-Chek Guide, Guide Me, and mySugr app
  • Exhibit 2-12: One Drop Mobile app, glucose meter/accessories, and the Apple Watch
  • Exhibit 2-13: Continuous glucose monitoring systems, by manufacturer, 2021
  • Exhibit 2-14: Selected continuous glucose monitoring systems and features, 2021
  • Exhibit 2-15: The original FreeStyle Libre 14-day CGM System
  • Exhibit 2-16: The new FreeStyle Libre 3 - world’s smallest 14-day sensor
  • Exhibit 2-17: The LibreLink and LinkUp apps
  • Exhibit 2-18: The new Libre Sense Glucose Sport Biosensor
  • Exhibit 2-19: The Dexcom G6 CGM System with extended 10-day sensor
  • Exhibit 2-20: The new Dexcom G7 CGM sensor
  • Exhibit 2-21: Dexcom CLARITY diabetes management software
  • Exhibit 2-22: The Guardian Connect CGM System with Sugar.IQ app
  • Exhibit 2-23: The iPro2 Professional CGM system with CareLink iPro software
  • Exhibit 2-24: The sugarBEAT system
  • Exhibit 2-25: How the sugarBEAT draws glucose from interstitial fluid
  • Exhibit 2-26: Senseonics’ Eversense Continuous Glucose Monitoring System and insertion procedure
3. Market Analysis
3.1 Blood glucose monitoring devices market
3.1.1 Market forecast: global
3.1.2 Market forecast: by region and segment
3.1.3 US market
3.1.4 Five major European markets
3.1.5 Japanese market
3.1.6 Rest of the world market
3.1.7 Market drivers and limiters
3.2 Competitive analysis
3.2.1 Market share: global/combined
3.2.2 Market share: by segment
3.2.3 Market share: by region
3.3 Corporate profiles
3.3.1 Abbott
3.3.2 Dexcom
3.3.3 Medtronic
3.3.4 Nemaura Medical
3.3.5 Roche
3.3.6 Senseonics
3.4 Bibliography
  • Exhibit 3-1: Blood glucose monitoring device sales by product segment (blood glucose meters and continuous glucose monitoring devices), combined market forecast ($m), 2019-25
  • Exhibit 3-2: Blood glucose monitoring devices market (blood glucose meters and continuous glucose monitoring devices) combined market forecast by region ($m), 2019-25
  • Exhibit 3-3: Blood glucose monitoring device sales by product segment and region, combined market forecast ($m), 2019-25
  • Exhibit 3-4: Combined blood glucose monitoring devices market (blood glucose meters and continuous glucose monitoring devices), global share by supplier ($m), 2019
  • Exhibit 3-5: Combined blood glucose monitoring devices market (blood glucose meters and continuous glucose monitoring devices), global share by supplier ($m), 2020
  • Exhibit 3-6: Blood glucose meters market, global share by supplier ($m), 2019
  • Exhibit 3-7: Blood glucose meters market, global share by supplier ($m), 2020
  • Exhibit 3-8: Continuous glucose monitoring systems market, global share by supplier ($m), 2019
  • Exhibit 3-9: Continuous glucose monitoring systems market, global share by supplier ($m), 2020
  • Exhibit 3-10: Combined blood glucose monitoring devices market, estimated share by supplier and region, 2019
  • Exhibit 3-11: Combined blood glucose monitoring devices market, estimated share by supplier and region, 2020
  • Exhibit 3-12: Abbott, revenues by segment, FY2018-20
  • Exhibit 3-13: Dexcom, revenues by segment, FY2018-20
  • Exhibit 3-14: Medtronic, revenues by segment, FY2018-20
  • Exhibit 3-15: Roche, revenues by segment, FY2018-20
  • Exhibit 3-16: Senseonics, revenues by segment, FY2018-20
Appendix A: Company listing
Note: Product cover images may vary from those shown
  • Abbott
  • Ascensia Diabetes Care
  • Dexcom
  • LifeScan
  • Medtronic
  • Roche
  • Senseonics
Note: Product cover images may vary from those shown
Adroll
adroll